GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Optigenex Inc (OTCPK:OPGX) » Definitions » Debt-to-EBITDA

Optigenex (Optigenex) Debt-to-EBITDA : -14.57 (As of Jun. 2008)


View and export this data going back to 2004. Start your Free Trial

What is Optigenex Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Optigenex's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2008 was $8.18 Mil. Optigenex's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2008 was $3.24 Mil. Optigenex's annualized EBITDA for the quarter that ended in Jun. 2008 was $-0.78 Mil. Optigenex's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2008 was -14.57.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Optigenex's Debt-to-EBITDA or its related term are showing as below:

OPGX's Debt-to-EBITDA is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.76
* Ranked among companies with meaningful Debt-to-EBITDA only.

Optigenex Debt-to-EBITDA Historical Data

The historical data trend for Optigenex's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optigenex Debt-to-EBITDA Chart

Optigenex Annual Data
Trend Dec04 Dec05 Dec06 Dec07
Debt-to-EBITDA
- -0.58 -1.84 -7.53

Optigenex Quarterly Data
Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.64 -7.69 -4.29 -16.80 -14.57

Competitive Comparison of Optigenex's Debt-to-EBITDA

For the Diagnostics & Research subindustry, Optigenex's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optigenex's Debt-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Optigenex's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Optigenex's Debt-to-EBITDA falls into.



Optigenex Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Optigenex's Debt-to-EBITDA for the fiscal year that ended in Dec. 2007 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4.514 + 4.427) / -1.187
=-7.53

Optigenex's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2008 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(8.182 + 3.243) / -0.784
=-14.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2008) EBITDA data.


Optigenex  (OTCPK:OPGX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Optigenex Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Optigenex's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Optigenex (Optigenex) Business Description

Traded in Other Exchanges
N/A
Address
901 Sam Rayburn Highway, Melissa, TX, USA, 75454
Optigenex Inc is an applied sciences company dedicated to solutions for healthy age management. The company offers AC-11, a powdered and bioactive rainforest plant extract that helps the body to repair sun and environmental stress-related damage to DNA, and slow down the process of skin aging.
Executives
Richard S Serbin director, 10 percent owner, officer: CEO, President & Secretary 750 LEXINGTON AVENUE, 6TH FLOOR, NEW YORK NY 10022

Optigenex (Optigenex) Headlines

No Headlines